NEWTON ROGER S

Average Profitability
8.67%
Insider Buys Quantity
1
Insider Buys Sum
$1.19M
Insider Sells Quantity
9
Insider Sells Sum
$7.39M

Insider Activity of NEWTON ROGER S

The largest purchase of all time was on 2013-07-01 and amounted to 84692 shares of Esperion Therapeutics, Inc. for $1.19M.

The largest sale of all time was on 2018-03-29 and amounted to 50000 shares of Esperion Therapeutics, Inc. for $3.62M.

Biography of NEWTON ROGER S

No biography is available at this moment.

2019-03-12SaleEsperion Therapeutics, Inc.
ESPR
director
25,000
0.0936%
$50.06$1.25M-8.63%
2018-11-02SaleEsperion Therapeutics, Inc.
ESPR
director
227
0.0008%
$50.76$11,523-21.56%
2018-11-01SaleEsperion Therapeutics, Inc.
ESPR
director
2,600
0.0097%
$50.01$130,026-12.13%
2018-10-18SaleEsperion Therapeutics, Inc.
ESPR
director
100
0.0004%
$50.00$5,000-8.46%
2018-10-17SaleEsperion Therapeutics, Inc.
ESPR
director
12,673
0.0473%
$50.02$633,903-11.51%
2018-10-16SaleEsperion Therapeutics, Inc.
ESPR
director
9,400
0.0351%
$50.01$470,094-11.42%
2018-08-27SaleEsperion Therapeutics, Inc.
ESPR
director
17,700
0.0656%
$51.05$903,610-10.93%
2018-08-17SaleEsperion Therapeutics, Inc.
ESPR
director
7,300
0.0283%
$50.06$365,438-3.99%
2018-03-29SaleEsperion Therapeutics, Inc.
ESPR
director
50,000
0.188%
$72.37$3.62M-37.04%
2013-07-01PurchaseEsperion Therapeutics, Inc.
ESPR
Executive Chairman, CSO
84,692
0.5519%
$14.00$1.19M+8.67%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.